RecruitingNCT06184503
Analysis of Velmanase Alfa (Lamzede®)'s Effects in the Body of Children With Alpha-Mannosidosis Under the Age 3
Studying Alpha-mannosidosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Intervention
- Velmanase Alfa(drug)
- Enrollment
- 5 enrolled
- Eligibility
- 3 years · All sexes
- Timeline
- 2025 – 2029
Study locations (2)
- Nicklaus Children's Hospital, Miami, Florida, United States
- Greenwood Genetic Center, Greenwood, South Carolina, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06184503 on ClinicalTrials.gov